Learn how to manage an IgA nephropathy flare with this detailed action plan. Understand symptoms and prevention to safeguard ...

A investigator reported that sibeprenlimab halved baseline proteinuria levels over 12 months in trial patients with IgA nephropathy. Sibeprenlimab continues to reduce proteinuria in patients with IgA ...

HOUSTON -- A novel self-administered shot that inhibits two key immunoregulatory cytokines reduced proteinuria in patients with IgA nephropathy, interim findings from the phase III ORIGIN 3 trial ...

BRISBANE, Calif., May 25, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for ...

(RTTNews) - Vera Therapeutics, Inc. (VERA), Thursday announced data from the ORIGIN Phase 3 trial of atacicept in IgA nephropathy, stating that the study met the primary endpoint with a statistically ...

Panelists discuss how patients with immunoglobulin A (IgA) nephropathy typically present with microscopic or gross hematuria, often during upper respiratory infections, along with variable proteinuria ...

IgA nephropathy is diagnosed through a combination of clinical findings, urine and blood tests, and a renal (kidney) biopsy. IgA nephropathy cannot be definitively diagnosed without a kidney biopsy.

Expert Rev of Obstet Gynecol. 2012;7(3):269-279. In summary, excess levels of urobilinogen and bilirubin in the urine may signal liver disease, and more research is needed to correlate these levels ...